Circulating ACE2 activity was elevated in patients with primary lung cancer (adenocarcinoma and squamous cell carcinoma) when compared to patients with metastasis or non-cancerous diseases (sarcoidosis, silicoanthracosis, pneumothorax, pneumonia, emphysema, Fig. 4A). This evidence concerns the gene ACE2 and squamous cell carcinoma.